BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Savarino E, Zentilin P, Marabotto E, Bodini G, Della Coletta M, Frazzoni M, de Bortoli N, Martinucci I, Tolone S, Pellegatta G, Savarino V. A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD). Expert Opin Pharmacother. 2017;18:1333-1343. [PMID: 28754071 DOI: 10.1080/14656566.2017.1361407] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Bardou M, Fortinsky KJ, Chapelle N, Luu M, Barkun A. An update on the latest chemical therapies for reflux esophagitis in children. Expert Opinion on Pharmacotherapy 2018;20:231-9. [DOI: 10.1080/14656566.2018.1549224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
2 Savarino V, Marabotto E, Zentilin P, Demarzo MG, de Bortoli N, Savarino E. Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art. Drug Des Devel Ther 2021;15:1609-21. [PMID: 33907381 DOI: 10.2147/DDDT.S306371] [Reference Citation Analysis]
3 Zaterka S, Marion SB, Roveda F, Perrotti MA, Chinzon D. HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT. Arq Gastroenterol 2019;56:202-8. [PMID: 31460587 DOI: 10.1590/S0004-2803.201900000-41] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Lechien JR, Akst LM, Saussez S, Crevier-buchman L, Hans S, Barillari MR, Calvo-henriquez C, Bock JM, Carroll TL. Involvement of Laryngopharyngeal Reflux in Select Nonfunctional Laryngeal Diseases: A Systematic Review. Otolaryngol Head Neck Surg 2021;164:37-48. [DOI: 10.1177/0194599820933209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 MacFarlane B. Management of gastroesophageal reflux disease in adults: a pharmacist's perspective. Integr Pharm Res Pract 2018;7:41-52. [PMID: 29892570 DOI: 10.2147/IPRP.S142932] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Remes-Troche JM, García García FD, Rojas-Loureiro G, Rivera-Gutiérrez X, Reyes-Huerta J, Amieva-Balmori M. Intragastric pH effect of 20mg of levo-pantoprazole versus 40mg of racemic pantoprazole the first seven days of treatment in patients with gastroesophageal reflux disease. Rev Gastroenterol Mex (Engl Ed) 2020;85:48-55. [PMID: 31104856 DOI: 10.1016/j.rgmx.2019.02.006] [Reference Citation Analysis]
7 Nicolau LA, Batista-lima FJ, Santana AP, Sales TM, Carmo-neto JP, Freitas GB, Oliveira TM, Medeiros JV, Silva DA, Lee C, Woodland PJ, Soares PM, Vale ML, Santos AA, Sifrim D, Souza MH. Cashew gum, a biopolymer, topically protects oesophageal mucosa in non erosive reflux disease: A promising translational study. Carbohydrate Polymers 2019;226:115205. [DOI: 10.1016/j.carbpol.2019.115205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Li X, Ding F, Luo P, Yang J, Liu Z, Liu J, Zhang Y, Leng A, Wu K. Study on the Therapeutic Effects of Drug and Cognitive-Behavioral Therapy on Non-Erosive Reflux Disease Patients With Emotional Disorders. Front Psychiatry 2018;9:115. [PMID: 29867593 DOI: 10.3389/fpsyt.2018.00115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Wang R, Wang J, Hu S. Study on the relationship of depression, anxiety, lifestyle and eating habits with the severity of reflux esophagitis. BMC Gastroenterol 2021;21:127. [PMID: 33743601 DOI: 10.1186/s12876-021-01717-5] [Reference Citation Analysis]
10 Lee JA, Shin MR, Kim MJ, Lee JH, Park HJ, Roh SS. Protective Effects of Inflammation of Curcumae Longae Rhizoma 30% EtOH Extract on Acute Reflux Esophagitis Rats. Biomed Res Int 2021;2021:8854945. [PMID: 33532497 DOI: 10.1155/2021/8854945] [Reference Citation Analysis]
11 Lechien JR, Bobin F, Muls V, Mouawad F, Dequanter D, Horoi M, Thill MP, Rodriguez Ruiz A, Saussez S. The efficacy of a personalised treatment depending on the characteristics of reflux at multichannel intraluminal impedance-pH monitoring in patients with acid, non-acid and mixed laryngopharyngeal reflux. Clin Otolaryngol 2021;46:602-13. [PMID: 33503317 DOI: 10.1111/coa.13722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Savarino E, Coletta MD. Symptom perception in patients with NERD: do nerves matter? Nat Rev Gastroenterol Hepatol 2017;14:634-6. [DOI: 10.1038/nrgastro.2017.120] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Watanabe SM, Ehrlich LS, Strickland M, Li X, Soloveva V, Goff AJ, Stauft CB, Bhaduri-McIntosh S, Tjandra N, Carter C. Selective Targeting of Virus Replication by Proton Pump Inhibitors. Sci Rep 2020;10:4003. [PMID: 32132561 DOI: 10.1038/s41598-020-60544-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
14 Qiu Y, Hu JL, Zhao CC, Zhang JQ, Wu F, Ma BL, Feng Y, Ruan KF. Zhujie Hewei Granules Ameliorated Reflux Esophagitis in Rats. Evid Based Complement Alternat Med 2019;2019:1392020. [PMID: 31949463 DOI: 10.1155/2019/1392020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Lechien JR, Bobin F, Muls V, Eisendrath P, Horoi M, Thill MP, Dequanter D, Durdurez JP, Rodriguez A, Saussez S. Gastroesophageal reflux in laryngopharyngeal reflux patients: Clinical features and therapeutic response. Laryngoscope 2020;130:E479-89. [PMID: 31876296 DOI: 10.1002/lary.28482] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
16 Savarino V, Marabotto E, Zentilin P, Furnari M, Bodini G, De Maria C, Tolone S, De Bortoli N, Frazzoni M, Savarino E. Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease. Expert Rev Clin Pharmacol 2020;13:437-49. [PMID: 32253948 DOI: 10.1080/17512433.2020.1752664] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lechien JR, Bock JM, Carroll TL, Akst LM. Is empirical treatment a reasonable strategy for laryngopharyngeal reflux? A contemporary review. Clin Otolaryngol 2020;45:450-8. [PMID: 32097534 DOI: 10.1111/coa.13518] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
18 Bhatia SJ, Makharia GK, Abraham P, Bhat N, Kumar A, Reddy DN, Ghoshal UC, Ahuja V, Rao GV, Devadas K, Dutta AK, Jain A, Kedia S, Dama R, Kalapala R, Alvares JF, Dadhich S, Dixit VK, Goenka MK, Goswami BD, Issar SK, Leelakrishnan V, Mallath MK, Mathew P, Mathew P, Nandwani S, Pai CG, Peter L, Prasad AVS, Singh D, Sodhi JS, Sud R, Venkataraman J, Midha V, Bapaye A, Dutta U, Jain AK, Kochhar R, Puri AS, Singh SP, Shimpi L, Sood A, Wadhwa RT. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol 2019;38:411-40. [PMID: 31802441 DOI: 10.1007/s12664-019-00979-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
19 Lechien JR, Mouawad F, Barillari MR, Nacci A, Khoddami SM, Enver N, Raghunandhan SK, Calvo-Henriquez C, Eun YG, Saussez S. Treatment of laryngopharyngeal reflux disease: A systematic review. World J Clin Cases 2019; 7(19): 2995-3011 [PMID: 31624747 DOI: 10.12998/wjcc.v7.i19.2995] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
20 Lechien JR, Bobin F, Muls V, Mouawad F, Dapri G, Dequanter D, Horoi M, Thill MP, Rodriguez Ruiz A, Saussez S. Changes of Laryngeal and Extralaryngeal Symptoms and Findings in Laryngopharyngeal Reflux Patients. Laryngoscope 2021;131:1332-42. [PMID: 32757218 DOI: 10.1002/lary.28962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Ribaldone DG, Rajesh P, Chandradhara D, Astegiano M, Pellicano R. A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptoms. Eur J Gastroenterol Hepatol 2021;32:163-70. [PMID: 32804843 DOI: 10.1097/MEG.0000000000001888] [Reference Citation Analysis]
22 Sales TMAL, do Nascimento RR, do Carmo Neto JP, da Costa Filho HB, Paula SM, Sousa MKA, de Melo Nogueira K, Junior GJD, da Silva DA, Soares PMG, Medeiros JVR, Nicolau LAD, Sifrim D, de Souza MHLP. Laryngeal and Esophageal Mucosal Protection Using the Angico Gum Biopolymer in a Mouse Model of Reflux. Laryngoscope 2022. [PMID: 35258096 DOI: 10.1002/lary.30093] [Reference Citation Analysis]
23 Cheng Y, Kou F, Liu J, Dai Y, Li X, Li J. Systematic assessment of environmental factors for gastroesophageal reflux disease: An umbrella review of systematic reviews and meta-analyses. Dig Liver Dis 2021;53:566-73. [PMID: 33339748 DOI: 10.1016/j.dld.2020.11.022] [Reference Citation Analysis]
24 Patel H, Desai N, Patel P, Modi N, Soni K, Patel JR, Mistry GN, Patel JD, Chawla M, Srinivas NR. Pharmacokinetic evaluation of differential drug release formulations of rabeprazole in dogs. Drug Dev Ind Pharm 2019;45:1459-67. [PMID: 31216902 DOI: 10.1080/03639045.2019.1628249] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Osadchuk AM, Davydkin IL, Gricenko TA, Osadchuk MA. Gastroesophageal reflux disease and esophagitis associated with the use of drugs: the modern state of the problem. Terapevticheskii arkhiv 2019;91:135-40. [DOI: 10.26442/00403660.2019.08.000228] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]